NGM Biopharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NGM Biopharmaceuticals Inc
CIK #0001426332
EDGAR Form CIK 2011 - 2023
10-K [0001426332]
10-Q [0001426332]
3 [0001426332]
4 [0001426332]
8-K [0001426332]
D [0001426332]
SC 13D [0001426332]
SC 13G [0001426332]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc NGM Biopharmaceuticals Inc [2023-02-09]
BlackRock Inc NGM Biopharmaceuticals Inc [2023-02-03]
EcoR1 Capital LLC NGM Biopharmaceuticals Inc [2022-10-28]
Rho Ventures V LP NGM Biopharmaceuticals Inc [2020-02-11]
Topspin Fund LP NGM Biopharmaceuticals Inc [2019-11-26]
Column Group L P NGM Biopharmaceuticals Inc [2019-04-12]
Merck & Co Inc NGM Biopharmaceuticals Inc [2019-04-09]
Form 3/4/5 Subject 2011 - 2023
Goeddel David V
NGM Biopharmaceuticals Inc
Guyer Shelly D
Rieflin William JL
Hooper Suzanne Sawochka
Ho Carole
Perlmutter Roger M
Chen Jin-Long
Lieu Hsiao D
Nolan Mangini Siobhan
View All
Terms | Privacy | Guide
tony@aum13f.com